POPULARITY
44 episodes with john torous
44 episodes with john torous
2 episodes with john torous
2 episodes with john torous
2 episodes with john torous
2 episodes with john torous
2 episodes with john torous
2 episodes with john torous
2 episodes with john torous
The promise for AI mental-health tools is clear: bringing support to people who need it, when they need it. But these chatbots can come with risks. How do they respond when someone is in crisis, or thinking about harming themselves? In Part Two of our special series “The AI Therapist,” WSJ What's News host Alex Ossola digs into the guardrails that companies are installing in their AI tools—and the questions as to whether they're enough. Episode 1 of The AI Therapist: When People Turn to Chatbots for Mental Health Further Reading: Chatbots Are Replacing Therapists With Little Scientific Evidence Behind Them Teens Seek Mental-Health Help From Chatbots. That's Dangerous, Says New Study. How AI Advice Is Undermining Eating-Disorder Therapy When There's No School Counselor, There's a Bot Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The millions of Americans living with mental illness—as well as people dealing with life's everyday stresses—often struggle to see a therapist when they need one. That's a big reason why many people have started turning to AI tools such as ChatGPT for emotional support. But as a number of high-profile lawsuits show, that can sometimes lead to devastating outcomes. Companies creating AI for mental health say they can do better. What's News host Alex Ossola and WSJ audio producer Pierre Bienaimé explore the growing field of these purpose-built tools, and how people are already using them, in Part 1 of our special series “The AI Therapist.” Further Reading: Chatbots Are Replacing Therapists With Little Scientific Evidence Behind Them Teens Seek Mental-Health Help From Chatbots. That's Dangerous, Says New Study. How AI Advice Is Undermining Eating-Disorder Therapy When There's No School Counselor, There's a Bot Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Can your smartphone become part of your mental health treatment? Prescription digital therapeutics (PDTs) promise to do exactly that — but what are they, and do they actually work? In this episode, host Gabe Howard is joined by ADAA member experts John Torous, MD, MBI, a digital psychiatry expert, and Michelle A. Patriquin, PhD, ABPP, a clinical psychologist, to separate hype from reality. Together, they explain what PDTs are — and aren't — and how mental health apps fit into modern treatment. The conversation explores how apps can help bridge long wait times for therapy; reinforce skills learned in treatment; track mood, sleep, and behavior between appointments; and provide valuable insights that improve conversations with mental health clinicians. Listeners will learn: the difference between FDA-approved mental health apps and standard wellness apps why choosing the "best" mental health app is less important than finding one you'll actually use consistently how to avoid common misconceptions about digital mental health tools and make informed choices If you've ever opened an app store looking for mental health support, this episode will help you separate marketing from evidence so you can make smarter, safer, and more informed decisions about incorporating technology into your mental health care. This episode has been sponsored by the Anxiety and Depression Association of America (ADAA). Our guest, Dr. Michelle Patriquin, is the John S. Dunn Distinguished Professor and Associate Professor in Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth Houston, and serves as Assistant Dean of Digital Health & Innovation in the UTHealth Houston School of Behavioral Sciences. She is also Co-Director of Research for the John S. Dunn Behavioral Sciences Center, the largest academic inpatient psychiatric hospital in the United States. She is a board-certified clinical psychologist and researcher focused on digital mental health: bringing data-driven, tech-enabled mental health care into real-world clinical setting - especially intensive and inpatient mental healthcare - to improve safety, recovery, and access. Her work is widely published and is supported by state, federal, and foundation funding. Our guest, John Torous, MD, MBI, is director of the digital psychiatry division in the Department of Psychiatry at Beth Israel Deaconess Medical Center (BIDMC), a Harvard Medical School-affiliated teaching hospital, where he also serves as a staff psychiatrist and associate professor. He has a background in electrical engineering and computer sciences and received an undergraduate degree in the field from UC Berkeley before attending medical school at UC San Diego. He completed his psychiatry residency, fellowship in clinical informatics, and master's degree in biomedical informatics at Harvard. Dr. Torous is active in investigating the potential of mobile mental health and AI technologies for psychiatry, and his team supports mindapps.org as the largest database of mental health apps, mindApps.ai for benchmarking AI chatbots, mindLAMP technology platform for scalable digital phenotyping and interventions, and the Digital Navigator program to promote digital equity and access. Dr. Torous has published over 300 peer reviewed articles and 5 book chapters on the topic. He directs the Digital Psychiatry Clinic at BIDMC which seeks to improve access to and quality of mental health care through augmenting treatment with digital innovations. Dr. Torous serves as editor-in-chief for the journal JMIR Mental Health, web editor for JAMA Psychiatry, and a member of various American Psychiatric Association committees.
En un debate de expertos organizado por el Centro Sadhguru para un Planeta Consciente y moderado por Matcheri Keshavan (profesor de la Facultad de Medicina de Harvard), Sadhguru, Swami Sarvapriyananda (ministro y líder espiritual de la Sociedad Vedanta de Nueva York), John Torous (profesor asociado de Psiquiatría en la Facultad de Medicina de Harvard y director de Psiquiatría Digital en el Centro Médico Beth Israel Deaconess), el Dr. Vikram Patel (catedrático Paul Farmer y director del Departamento de Salud Global y Medicina Social de la Facultad de Medicina de Harvard) y la Dra. Shirley Yen (profesora adjunta de Psicología, Facultad de Medicina de Harvard) exploraron la inteligencia artificial, la salud mental y la consciencia. El debate abordó algunas de las mayores cuestiones existenciales de la humanidad: si la IA puede sustituir a los seres humanos y si se avecina una crisis de salud mental. #sadhguruespañol #espiritualidad #consciencia #IA #InteligenciaArtificial #salud #saludmental Learn more about your ad choices. Visit megaphone.fm/adchoices
Interview with Dan-Mircea Mirea, MSci, author of The Reinforcement Effect of Social Media Likes in Depression. Hosted by John Torous, MD. Related Content: The Reinforcement Effect of Social Media Likes in Depression Do Likes Reinforce Depression?
Interview with Dan-Mircea Mirea, MSci, author of The Reinforcement Effect of Social Media Likes in Depression. Hosted by John Torous, MD. Related Content: The Reinforcement Effect of Social Media Likes in Depression Do Likes Reinforce Depression?
Interview with Husseini K. Manji, MD, author of The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review. Hosted by John Torous, MD. Related Content: The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia
Interview with Husseini K. Manji, MD, author of The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review. Hosted by John Torous, MD. Related Content: The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia
Interview with Hemant Bhargav, MD, PhD, author of Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Yoga for Opioid Withdrawal and Autonomic Regulation
Interview with Hemant Bhargav, MD, PhD, author of Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Yoga for Opioid Withdrawal and Autonomic Regulation
Dr. John Torous (He/his), MD is a Psychiatrist, Director: digitalpsych.org at Beth Israel Deaconess Medical Center, an expert in “mobile mental health technologies” and an Unapologetically Black Unicorn. Dr. Torous shares the concept behind MindApp.org and the connection between technology and mental health. They talk his tech background, how to navigate the privacy settings through your apps, the oversight of the digital mental health space and he the need for digital literacy. The National Suicide Prevention Lifeline is now: 988 Suicide and Crisis Lifeline Contact the show: UBU@UnapologeticallyBlackUnicorns.info Transcripts are available on Apple Podcasts.
Interview with Balázs Szigeti, PhD, author of Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions
Interview with Balázs Szigeti, PhD, author of Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions
Interview with Christian S. Hendershot, PhD, and Klara R. Klein, MD, PhD, authors of Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder Semaglutide Shows Promise in Reducing Alcohol Cravings
Interview with Christian S. Hendershot, PhD, and Klara R. Klein, MD, PhD, authors of Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder Semaglutide Shows Promise in Reducing Alcohol Cravings
Interview with Christian A. Webb, PhD, author of Predicting Adolescent Response to School-Based Mindfulness: A Secondary Analysis of the MYRIAD Trial. Hosted by John Torous, MD. Related Content: Predicting Adolescent Response to School-Based Mindfulness
Interview with Christian A. Webb, PhD, author of Predicting Adolescent Response to School-Based Mindfulness: A Secondary Analysis of the MYRIAD Trial. Hosted by John Torous, MD. Related Content: Predicting Adolescent Response to School-Based Mindfulness
Interview with Amy N. Cohen, PhD, and Matthew Chinman, PhD, authors of Tailored Weight Loss Programs for Adults With Serious Mental Illness: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Tailored Weight Loss Programs for Adults With Serious Mental Illness
Interview with Amy N. Cohen, PhD, and Matthew Chinman, PhD, authors of Tailored Weight Loss Programs for Adults With Serious Mental Illness: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Tailored Weight Loss Programs for Adults With Serious Mental Illness
Interview with Declan M. McLoughlin, PhD, author of Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression
Interview with Declan M. McLoughlin, PhD, author of Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression
Interview with Sharmili Edwin Thanarajah, MD, author of Soft Drink Consumption and Depression Mediated by Gut Microbiome Alterations. Hosted by John Torous, MD. Related Content: Soft Drink Consumption and Depression Mediated by Gut Microbiome Alterations GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain
Interview with Sharmili Edwin Thanarajah, MD, author of Soft Drink Consumption and Depression Mediated by Gut Microbiome Alterations. Hosted by John Torous, MD. Related Content: Soft Drink Consumption and Depression Mediated by Gut Microbiome Alterations GLP-1 Receptor Agonists for Pharmacologically Induced Weight Gain
Interview with Anna D. Ratzliff, MD, PhD and Andrew J. Saxon, MD authors of Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Trial. Hosted by John Torous, MD. Related Content: Collaborative Care for Opioid Use Disorder in Primary Care
Interview with Anna D. Ratzliff, MD, PhD and Andrew J. Saxon, MD authors of Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Trial. Hosted by John Torous, MD. Related Content: Collaborative Care for Opioid Use Disorder in Primary Care
Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Incidence and Nature of Antidepressant Discontinuation Symptoms
Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Incidence and Nature of Antidepressant Discontinuation Symptoms
Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Incidence and Nature of Antidepressant Discontinuation Symptoms
Interview with Aaron Alexander-Bloch, MD, PhD, and Kevin Y. Sun, BA, authors of Polygenic Risk, Psychopathology, and Personalized Functional Brain Network Topography in Adolescence. Hosted by John Torous, MD. Related Content: Polygenic Risk, Psychopathology, and Personalized Functional Brain Network Topography in Adolescence
Interview with Aaron Alexander-Bloch, MD, PhD, and Kevin Y. Sun, BA, authors of Polygenic Risk, Psychopathology, and Personalized Functional Brain Network Topography in Adolescence. Hosted by John Torous, MD. Related Content: Polygenic Risk, Psychopathology, and Personalized Functional Brain Network Topography in Adolescence
Interview with Pim Cuijpers, PhD, author of Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses. Hosted by John Torous, MD Related Content: Cognitive Behavior Therapy for Mental Disorders in Adults
Interview with Pim Cuijpers, PhD, author of Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses. Hosted by John Torous, MD Related Content: Cognitive Behavior Therapy for Mental Disorders in Adults
Interview with Professor Jurgen Unutzer, MD, author of Effective Components of Collaborative Care for Depression in Primary Care: An Individual Participant Data Meta-Analysis. Hosted by John Torous, MD. Related Content: Effective Components of Collaborative Care for Depression in Primary Care
Interview with Professor Jurgen Unutzer, MD, author of Effective Components of Collaborative Care for Depression in Primary Care: An Individual Participant Data Meta-Analysis. Hosted by John Torous, MD. Related Content: Effective Components of Collaborative Care for Depression in Primary Care
Interview with Srividya N. Iyer, PhD, author of An Approach to Providing Timely Mental Health Services to Diverse Youth Populations. Hosted by John Torous, MD. Related Content: An Approach to Providing Timely Mental Health Services to Diverse Youth Populations
Interview with Srividya N. Iyer, PhD, author of An Approach to Providing Timely Mental Health Services to Diverse Youth Populations. Hosted by John Torous, MD. Related Content: An Approach to Providing Timely Mental Health Services to Diverse Youth Populations
Interview with Jonathan Cantor, PhD, author of Changes in Specialty Crisis Services Offered Before and After the Launch of the 988 Suicide and Crisis Lifeline. Hosted by John Torous, MD. Related Content: Changes in Specialty Crisis Services Offered Before and After the Launch of the 988 Suicide and Crisis Lifeline
Interview with Jonathan Cantor, PhD, author of Changes in Specialty Crisis Services Offered Before and After the Launch of the 988 Suicide and Crisis Lifeline. Hosted by John Torous, MD. Related Content: Changes in Specialty Crisis Services Offered Before and After the Launch of the 988 Suicide and Crisis Lifeline
Interview with Jayani Jayawardhana, PhD, author of Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning. Hosted by John Torous, MD, MBI. Related Content: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
Interview with Jayani Jayawardhana, PhD, author of Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning. Hosted by John Torous, MD, MBI. Related Content: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
Interview with Daniel T. Myran, MD, MPH, author of Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder. Hosted by John Torous, MD. Related Content: Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder
Interview with Daniel T. Myran, MD, MPH, author of Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder. Hosted by John Torous, MD. Related Content: Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder
Interview with Benoit H. Mulsant, MD, MS, and Tarek K. Rajji, MD, authors of Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial. Hosted by John Torous, MD, MBI. Related Content: Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment
Interview with Benoit H. Mulsant, MD, MS, and Tarek K. Rajji, MD, authors of Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial. Hosted by John Torous, MD, MBI. Related Content: Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment
Interview with David B. Yaden, PhD, and Jared T. Hinkle, MD, PhD, authors of Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Adverse Events in Studies of Classic Psychedelics
Interview with David B. Yaden, PhD, and Jared T. Hinkle, MD, PhD, authors of Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Adverse Events in Studies of Classic Psychedelics
Interview with Jonathan A. C. Sterne, PhD, author of COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People. Hosted by John Torous, MD. Related Content: COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People
Interview with Jonathan A. C. Sterne, PhD, author of COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People. Hosted by John Torous, MD. Related Content: COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People
Interview with Robert D. Gibbons, PhD, and Ronald C. Kessler, PhD, authors of Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders. Hosted by John Torous, MD, MBI. Related Content: Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders
Interview with Vadim Zipunnikov, PhD, author of Integrative Modeling of Accelerometry-Derived Sleep, Physical Activity, and Circadian Rhythm Domains With Current or Remitted Major Depression. Hosted by John Torous, MD, MBI. Related Content: Integrative Modeling of Accelerometry-Derived Sleep, Physical Activity, and Circadian Rhythm Domains With Current or Remitted Major Depression
© 2020-2026 Ivy Podcast Discovery LLC
